Zhiyun Health (09955) announced that on March 10, 2025, the company, along with the subscribers and the exclusive placement...
According to the announcement from Zhitong Finance APP, Zhiyun Health (09955) has signed a subscription agreement with the subscribers and the exclusive placement agent on March 10, 2025, regarding the issuance of convertible Bonds with a total principal amount of 4.5 million US dollars to the subscribers.
After conversion at the initial conversion price of 2.10 Hong Kong dollars per share (which can be adjusted), a total of 16.6455 million shares will be issued as convertible shares, accounting for approximately 2.58% of the company's existing issued capital and approximately 2.51% of the company's issued capital after the expansion due to the issuance of convertible shares. The convertible shares will be issued in accordance with the general authorization.
The group plans to use the proceeds from the issuance of convertible Bonds as follows: approximately 2.25 million US dollars will be used to develop the group's daily Business, including the development of the patient-to-manufacturer (P2M) pipeline and the expansion of pharmacy Saas (Software as a Service); and approximately 2.25 million US dollars will be used for general working capital.
Comment(0)
Reason For Report